... stage smallcelllung cancer. Int J Radiat Oncol Biol Phys 1999, 43:39-45.31. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors predicting radiation pneumonitis in lungcancer ... chemotherapy and IMRT [21].More clinical evidence on using IMRT in treating lung cancer is needed.We started using IMRT to treat lungcancer in 2005,and we evaluated clinical and dosimetric factors ... cited.ResearchAnalysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non -small celllungcancer treated with concurrent...
... non -small- celllung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non -small celllung ... non -small- cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52:382-389.16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non -small celllung ... for lungcancer varied greatly frominstitution to institution [10]. The most frequently usedschedule was 48 Gy in 4 fractions for both stage IA andIB primary lungcancer and metastatic lung cancer. As...
... committee, ClinicalTrials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan and 3JCOG lungcancer ... quality assurance review in a multi-center randomized trial of limited-disease smallcelllung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202Naoko Sanuki-Fujimoto†1, Satoshi Ishikura*†1,2, ... Nishiwaki3 and Tomohide Tamura3Address: 1 Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo...
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non -small CellLungCancer Collaborative Group: Chemotherapyin non smallcelllung cancer: a meta-analysis ... docetaxel as first-line chemotherapy inpatients with advanced non -small celllung cancer: a lung cancer Galician group phase II study. Cancer Chemother Pharma-col 2007, 60:725-732.20. Binder D, ... Innovative sequence of docetaxel-gemcitabinebased on preclinical data in the treatment of advanced non small celllung cancer: a phase I study. LungCancer 2005,47:261-267.19. Casal J, Amenedo M,...
... Non -small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... ofdetecting EGFR mutations in lungcancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lungcancer (NSCLC) cell lines and tumor ... clinical practice for screening EGFR mutations in NSCLC patients.BackgroundNon -small- celllungcancer (NSCLC) is one of the mostfrequent human malignancies, constituting about 80% ofall lung...
... for clinical- pathological reasons are often dividedinto two broad categories: smallcelllungcancer (SCLC) and non -small celllungcancer (NSCLC). All majorhistological types of lungcancer ... act as a risk marker of lungcancer in Taiwan. Cancer 2003,97:1558-1563.11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in lung cancer. LungCancer 2009, 65:13-18.12. ... oesophagus, head andneck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To validate thehypothesis of HPV involvement in smallcelllungcancer pathogenesis...
... marker expression in tumor cells versus stromal cells in non small celllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. ... tumorepithelial cells and stromal compartment in non -small celllung cancer. Anticancer Res 2009, 29:4175-83.28. Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes RM, Busund LT: Clinical significance ... innon -small celllung cancer. Clin Cancer Res 2008, 14:5220-7.30. Andersen S, Eilertsen M, Donnem T, et al: Diverging prognostic impacts ofhypoxic markers according to NSCLC histology. Lung Cancer...
... Staging of small cell and non -small celllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for International Cancer ... UK.References1. NICE: Lung cancer: diagnosis and treatment. London: NationalInstitute for Clinical Excellence; 2005. 2. Scottish Executive Health Department: Cancer scenarios: an aidto planning cancer services...
... non -small celllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- celllungcancer patients for clinical ... cause of cancer death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC accounts for ... in non -small cell lungcancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non -small- celllung cancer...
... induced byfirst-line chemotherapy with single agentdocetaxel in a patient with advanced non small celllung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, ... Carteni’1AbstractBackground: Defining the optimal treatment for patients with inoperable non smallcelllungcancer (NSCLC),presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, ... few cycles should notautomatically discourage to continue treatment.IntroductionIn non -small celllungcancer (NSCLC), mediastinallymphnode involvement comprises a wide spectrum ofseverity....
... morphological characteristics ofpermanent human smallcelllungcancercell lines. J Cancer Res ClinOncol 1987, 113:31-40.16. NCCN guidelines for small- celllung cancer. [http://www.nccn.org/professionals/physician_gls/f_guidelines.asp].17. ... limited-stage smallcelllung cancer. [http://clinicaltrials.gov/ct2/show/NCT00433563].27. Three different radiation therapy regimens in treating patients withlimited-stage smallcelllungcancer ... in limited-stage small celllung cancer: facts, questions, prospects. Radiother Oncol 2000, 55:1-9.2. Murray N, Turrisi AT: A review of first-line treatment for small- cell lung cancer. J Thorac...
... prospective clinical studies are needed.Keywords: Stereotactic Body Rad iotherapy, Oligometastases, Non -Small CellLung Cancer BackgroundNon -small celllungcancer (NSCLC) is the leadingcause of cancer ... Okunieff2and Michael T Milano1*AbstractBackground: Standard therapy for metastatic non smallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies ... Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non -small celllung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul...
... patients withoperable lung cancer. A randomized phase III trial of Radiosurgery Or Surgeryfor operable Early stage (stage 1A) non -small cell Lung cancer (ROSEL, ClinicalTrials.gov ID = NCT00687986)has ... radiotherapy for stage Inon -small celllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana university ... options for stage Inon -small celllung cancer. Oncologist 2008, 13:309-319.41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M:Review of Hypofractionated Small Volume Radiotherapy...
... energy agency (IAEA)consultants' meeting on elective nodal irradiation in lung cancer: non -small celllungcancer (NSCLC). Int J Radiat OncolBiol Phys 2008, 72(2):335-342.6. Therasse P, ... in non -small celllung cancer Erik P Sulman, Ritsuko Komaki, Ann H Klopp, James D Cox and Joe Y Chang*Address: Department of Radiation Oncology, the University of Texas M. D. Anderson Cancer ... node stations.Methods: We retrospectively reviewed the records of 115 patients with non -small cell lung cancer treated at our institution with definitive radiation therapy with or without concurrentchemotherapy...
... relationshipbetween the target and the parotid glands [8]. Similarfindings were made for non -small- celllung cancer (NSCLC), where a continuous tumor regression duringradiotherapy was observed [9].This ... WagnerTH, Langen KM: Serial megavoltage CT imaging during exter-nal beam radiotherapy for non -small- celllung cancer: obser-vations on tumor regression during treatment. Int J RadiatOncol Biol Phys ... AccessResearchEvalution of surface-based deformable image registration for adaptive radiotherapy of non -small celllungcancer (NSCLC)Matthias Guckenberger*, Kurt Baier, Anne Richter, Juergen Wilbert and Michael...